Jeffrey J. Hsu, MD, PhD

Dr. Hsu received his undergraduate education at MIT, where he double-majored in Mechanical Engineering and Biology, and he subsequently received a Masters of Engineering in Biomedical Engineering at MIT. He attended medical school at the David Geffen School of Medicine at UCLA, and received his Internal Medicine residency training at UCSF Medical Center. He completed his General Cardiology and Advanced Heart Failure/Transplant fellowships at UCLA Medical Center, where he served as Chief Fellow. As a fellow in the UCLA STAR Program, he received his Ph.D. in the UCLA Molecular Cellular & Integrative Physiology (MCIP) department, in which he focused on molecular imaging of cardiovascular development and disease. Currently, he is a Principal Investigator in the UCLA Cardiovascular Calcification Research Laboratory, with research support from the NIH and the American Heart Association. His research interests include understanding the effects of exercise on cardiovascular health, exploring the mechanisms of exercise intolerance and post-exertional malaise in Long COVID, and developing novel tools to promote safe exercise in people with heart disease. 

Dr. Hsu is actively involved in the American Heart Association (AHA). He is a fellow of the AHA (FAHA), and he currently serves as Chair of the AHA ATVB Membership Committe, as a Technical Editor for the AHA journal, Circulation, and as an editorial board member for the journal, Circulation Research. He is also an active member of the American College of Cardiology (ACC). Further, he is an active member of the American College of Cardiology (ACC). He served as Chair of the programming committee for the ACC.26 Care of the Athletic Heart sports cardiology conference, and he is a member of the ACC Sports and Exercise Cardiology leadership council. Dr. Hsu is Co-Director of the UCLA Sports Cardiology Program, and he is a team cardiologist for the Los Angeles Lakers, Los Angeles Sparks, Los Angeles Dodgers, and UCLA Athletics.